ENVOY MEDICAL, INC.: pre-tax income or loss from continuing operations
Pre-tax income or loss from continuing operations for ENVOY MEDICAL, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ENVOY MEDICAL, INC. financial histories
What this measure means
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
Exact concept: us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2021-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -23,756,000 | USD | 2026-03-23 | 10-K · 0001213900-26-032683 |
| 2024-01-01 | 2024-12-31 | -20,795,000 | USD | 2026-03-23 | 10-K · 0001213900-26-032683 |
| 2022-01-01 | 2022-12-31 | 20,735,424 | USD | 2023-04-03 | 10-K · 0001104659-23-040842 |
| 2021-01-01 | 2021-12-31 | -251,633 | USD | 2023-04-03 | 10-K · 0001104659-23-040842 |
Related financial histories
- ENVOY MEDICAL, INC.: total assets
- ENVOY MEDICAL, INC.: total liabilities
- ENVOY MEDICAL, INC.: stockholders equity
- ENVOY MEDICAL, INC.: cash and cash equivalents
- ENVOY MEDICAL, INC.: net income or loss
- ENVOY MEDICAL, INC.: operating cash flow
- ENVOY MEDICAL, INC.: capital expenditure payments
- ENVOY MEDICAL, INC.: revenue
- ENVOY MEDICAL, INC.: financing cash flow
- ENVOY MEDICAL, INC.: investing cash flow
- ENVOY MEDICAL, INC.: retained earnings or deficit
- ENVOY MEDICAL, INC.: basic weighted-average shares
- ENVOY MEDICAL, INC.: diluted weighted-average shares
- ENVOY MEDICAL, INC.: basic earnings per share
- ENVOY MEDICAL, INC.: diluted earnings per share
- ENVOY MEDICAL, INC.: net property, plant and equipment
- ENVOY MEDICAL, INC.: share-based compensation expense
- ENVOY MEDICAL, INC.: operating income or loss
- ENVOY MEDICAL, INC.: current assets
- ENVOY MEDICAL, INC.: current liabilities
- ENVOY MEDICAL, INC.: current accounts payable
- ENVOY MEDICAL, INC.: net current accounts receivable
- ENVOY MEDICAL, INC.: net inventory
- ENVOY MEDICAL, INC.: research and development expense
- ENVOY MEDICAL, INC.: cash including restricted cash
- ENVOY MEDICAL, INC.: additional paid-in capital
- ENVOY MEDICAL, INC.: accumulated other comprehensive income or loss
- ENVOY MEDICAL, INC.: operating lease liability
- ENVOY MEDICAL, INC.: gross property, plant and equipment
- ENVOY MEDICAL, INC.: accumulated depreciation on property, plant and equipment
- ENVOY MEDICAL, INC.: accrued current liabilities
- ENVOY MEDICAL, INC.: prepaid expenses and other current assets
- ENVOY MEDICAL, INC.: net deferred tax assets
- ENVOY MEDICAL, INC.: comprehensive income or loss
- ENVOY MEDICAL, INC.: net income available to common stockholders
- ENVOY MEDICAL, INC.: general and administrative expense
- ENVOY MEDICAL, INC.: depreciation expense
- ENVOY MEDICAL, INC.: other nonoperating income or expense
- ENVOY MEDICAL, INC.: nonoperating income or expense
- ENVOY MEDICAL, INC.: deferred income tax expense or benefit
- ENVOY MEDICAL, INC.: interest paid, net
- ENVOY MEDICAL, INC.: change in accounts receivable
- ENVOY MEDICAL, INC.: change in inventories
- ENVOY MEDICAL, INC.: change in accounts payable
Inspect the source
- Entity
- ENVOY MEDICAL, INC. / CIK 0001840877
- Captured
- 2026-09-21T17:31:25.374Z
- SEC response SHA-256
a237ac20b6431ac6e0fb80d9114f329934463c38b5d933adbb90a22438392a65
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001840877.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))